Beijing Food and Drug Administration exposed 9 batches of unqualified drugs

According to the Xinhua News Agency, the Beijing Municipal Food and Drug Administration issued a drug quality announcement in the third quarter of this year, and nine batches of commonly used drugs such as Sanhuang Tablets, Changyanning and Ganmao Qingre Granules were found to be ineligible because of their traits and contents. The Beijing Municipal Bureau of Food and Drug Control stated that the unqualified drugs that were exposed would be handled according to law and they would be strongly encouraged to follow up on random inspections.

The nine batches of unqualified drugs were: ibuprofen sustained-release capsules produced by Jilin Daojun Pharmaceutical Co., Ltd.; Changyan Ning Granules produced by Hainan New Zhongzheng Pharmaceutical Co., Ltd.; and simvastatin produced by Shandong Xinqi Pharmaceutical Co., Ltd. Tablet; Sanhuang Tablet produced by Shandong Jianmin Pharmaceutical Co., Ltd.; Kaisailu produced by Qingdao Huarentai Pharmaceutical Co., Ltd.; Yinhuang Granule produced by Jilin Fusong County Traditional Chinese Medicine Co., Ltd.; produced by Guangxi Tiantianle Pharmaceutical Co., Ltd. The cold-heat-removing particles; Jilin Liuhe Fangda Pharmaceutical Co., Ltd. produced quick-acting antidiarrheal capsules; Beijing Yawei Herbal Decoction Co., Ltd. produced Shandougen.